Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Controlled Trial Investigating the Use of Next-generation Sequencing in Directing the Antimicrobial Treatment of Periprosthetic Joint Infection

NCT05247281 is registered in ClinicalTrials.gov with Center for Innovation and Research Organization as lead sponsor.

NCT NCT05247281
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05247281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Controlled Trial Investigating the Use of Next-generation Sequencing in Directing the Antimicrobial Treatment of Periprosthetic Joint Infection
Lead sponsor
Center for Innovation and Research Organization
Phase
Not applicable
Overall status
Unknown status
Start date
September 21, 2022
Completion date
May 31, 2025
Enrollment
250 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

prosthetic joint infection